Literature DB >> 45891

Different hematological diseases induced by type C viruses chemically activated from embryo cells of different mouse strains.

J S Greenberger, J R Stephenson, W C Moloney, S A Aaronson.   

Abstract

Type C RNA viruses can be induced by certain chemicals from cells of many mouse strains. Both C58 and BALB/c cells have been shown to contain endogenous viruses that are designated N-tropic because they grow preferentially in cells of NIH Swiss mouse origin. While demonstrating many similar biological and immunological properties, the C58-induced virus is around 10-fold more infectious per physical particle than the N-tropic virus of BALB/c cells. In the present studies, inoculation of these viruses into newborn NIH Swiss mice led to the development of diseases associated with splenomegaly and lymphadenopathy at similar frequency in each group. The disease induced by C58-MuLV was histophathologically diagnosed as lymphoblastic leukemia and was highly malignant following transplantation into newborn mice. The histopathological appearance of spleens from BALB/c virus-affected animals was distinguishable, demonstrating instead myeloid metaplasia or myelogenous leukemia. These findings provide evidence that different endogenous mouse type C viruses can induce distinct diseases in the same mouse strain. Furthermore, they implicate the N-tropic virus endogenous to C58 cells as a major factor in the development of lymphoblastic leukemia that occurs at high frequency in that strain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 45891

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Hemopoietic stem cells and target cells in murine-virus-induced leukemias.

Authors:  H J Seidel
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Rat sequences of the Kirsten and Harvey murine sarcoma virus genomes: nature, origin, and expression in rat tumor RNA.

Authors:  G R Anderson; K C Robbins
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

3.  Spontaneous expression of C-type virus in DBA/2 mice is associated with an increased rate of mortality, independent of neoplastic disease.

Authors:  K Ulrich; B A Nexø
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  In vitro selection of high-infectious, leukemogenic virus from low-infectious, non-leukemogenic type C virus from a malignant ST/a mouse cell line.

Authors:  B M Willumsen
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

5.  Segregation of genetic information for a B-tropic leukemia virus with the structural locus for BALB:virus-1.

Authors:  K C Robbins; C D Cabradilla; J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Kinetics of expression of infectious ecotropic, xenotropic, and mink cell focus-forming murine leukemia virus after 5-iododeoxyuridine induction of cells from high- and low-leukemia mouse strains.

Authors:  U R Rapp
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  Thymotropism of murine leukemia virus is conferred by its long terminal repeat.

Authors:  L DesGroseillers; E Rassart; P Jolicoeur
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Modulation of radiation-induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy.

Authors:  Michael W Epperly; Tracy Dixon; Hong Wang; James Schlesselman; Darcy Franicola; Joel S Greenberger
Journal:  Radiat Res       Date:  2008-10       Impact factor: 2.841

9.  Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia.

Authors:  C D Scher
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Continuous replication of Friend virus complex (spleen focus-forming virus-lymphatic leukemia-inducing virus) in mouse embryo fibroblasts. Retention of leukemogenicity and loss of immunosuppressive properties.

Authors:  R J Eckner
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.